Lv1
70 积分 2025-12-09 加入
Harnessing biosynthetic logic for next-generation ADC payloads
1个月前
已完结
The next generation of antibody–drug conjugates
1个月前
已完结
520LBA (PB-520) LBA Posters: Preclinical characterization of LY4175408, a novel PTK7 targeting antibody-drug conjugate, utilizing exatecan via a hydrophilic polysarcosine linker platform
1个月前
已关闭
Recent advances in function-enhanced antibody-drug conjugates: Antibody optimization and payload combination
1个月前
已完结
Rovadicitinib in Patients with Myelofibrosis Who Were Refractory or Relapsed or Intolerant to Ruxolitinib: A Single Arm, Multicenter, Open-Label, Phase Ib Study
7个月前
已关闭
Recent Advances in Peptide Linkers for Antibody-Drug Conjugates
7个月前
已完结
AbClick Pro H: Scavenger-Free, Traceless Lys248 Conjugation Via O -Acyl Hydroxamate Chemistry for Homogeneous Antibody–Drug Conjugates (ADCs)
8个月前
已完结
Efficient Preparation of Homogenous Antibody Conjugates via Glycosite‐Specific Transglycosylation Enabled by Readily Available Glycosyl Donors
8个月前
已完结
Transglutaminase-Mediated Conjugations
8个月前
已完结
Site-specific construction of triptolide-based antibody-drug conjugates
8个月前
已完结
皖公网安备34019202002308
